Center for Reproductive Medicine, Minneapolis, MN – FDA Inspections

Inspection records and compliance data for Center for Reproductive Medicine in Minneapolis, Minnesota. 6 FDA inspections on record, last inspected February 06, 2025.

Company Profile

This profile covers Center for Reproductive Medicine based in Minneapolis, Minnesota, United States.

FDA Inspection History

FDA inspections: 6
OAI: 0
VAI: 1
NAI: 4
Unclassified: 1
Form 483s: 0
Warning letters: 0

First inspected March 16, 2010. Last inspected February 6, 2025.

Most cited issue areas

Kits not FDA approved, specifically labeled1 inspection
Procedures for all other requirements1 inspection

FDA inspections (6)

Date	Result	FDA center(s)	Insp. #
February 6, 2025	Not classified	Biologics	1260495
October 2, 2019	NAI	Biologics · Blood and Blood Products	1107360
September 1, 2017	NAI	Biologics · Blood and Blood Products	1025777
July 31, 2014	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	889603
August 6, 2012	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	795285
March 16, 2010	VAI	Biologics · Human Cellular, Tissue, and Gene Therapies	654606

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Reproductive Medicine & Infertility Associates

The American National Red Cross

Innovative Blood Resources, a Division of New York Blood Center, Inc. d.b.a. Memorial Blood Centers

Osteologic, Inc

Innovative Blood Resources a Division of New York Blood Center Inc., dba Memorial Blood Centers

Cambridge Medical Center - Allina Health Laboratory

Mayo Clinic Health System Mankato

CSL Plasma Inc.

Reding, Mark T., M.D., Clinical Investigator

Sahil (nmi) Khanna, MBBS, MS, Clinical Investigator